Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.75 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.59 |
| ▸ | ABAT | P80404 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | JAK1 | P23458 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL5090009 | 0.92 | AKT1 (0.69) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| SCHEMBL4315033 | 0.91 | ALDH5A1 (0.70) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| SCHEMBL38134 | 0.86 | AKT1 (1.00) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| Benzene SCHEMBL27516217 | 0.86 | AKT1 (1.00) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| Formaldehyde SCHEMBL27801880 | 0.84 | AKT1 (0.95) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| Methane SCHEMBL27566869 | 0.84 | AKT1 (0.95) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| Ammonia Solution, Strong SCHEMBL6567239 | 0.84 | AKT1 (0.95) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| Fluoride SCHEMBL27784734 | 0.84 | AKT1 (0.95) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| Ethylene SCHEMBL27565387 | 0.84 | AKT1 (0.95) | AKT1ALDH5A1ABATSMN1; SMN2MAPT | |
| SCHEMBL902533 | 0.84 | KMO (0.62) | AKT1ALDH5A1ABATLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7105274-B2 | Photoluminescent ethylene sensors | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2006-09-12 | — | — | US | claimed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-8937091-B2 | Inhibitor of protein crosslinking and use of the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2015-01-20 | — | — | US | disclosed |
| US-8937091-B2 | Inhibitor of protein crosslinking and use of the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2015-01-20 | — | — | US | disclosed |
| US-8613985-B2 | Liquid crystal/polymer composite | KABUSHIKI KAISHA TOSHIBA (JP) | 2013-12-24 | — | — | US | disclosed |
| US-20120307184-A1 | LIQUID CRYSTAL/POLYMER COMPOSITE | KABUSHIKI KAISHA TOSHIBA (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120277423-A1 | PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 2012-11-01 | — | — | US | disclosed |
| US-20120277423-A1 | PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 2012-11-01 | — | — | US | disclosed |
| US-7803822-B2 | Triazole derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20090105253-A1 | Triazole Derivative and Use Thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-23 | — | — | US | disclosed |
| US-7105274-B2 | Photoluminescent ethylene sensors | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2006-09-12 | — | — | US | disclosed |
| US-20050031985-A1 | Photoluminescent ethylene sensors | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2005-02-10 | — | — | US | disclosed |
| EP-0885869-A1 | THERAPEUTIC AGENT FOR DIABETES | Japan Tobacco Inc. (JP) | 1998-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105253-A1 | Triazole Derivative and Use Thereof | F2R, HRH4, F2RL3 | AKT1 2272/4885ALDH5A1 4016/4885ABAT 4525/4885 |
| US-20120277423-A1 | PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME | ARGLU1, F12, CDKL1 | AKT1 1984/4885ALDH5A1 3620/4885ABAT 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.